Technologies Available for Partnering
Our commitment to innovative research spans a wide spectrum of technologies. From uncovering novel therapeutic targets and pioneering precise diagnostics platforms to harnessing the power of artificial intelligence to expedite the pace of discovery, we push the boundaries of what’s possible in the fight against cancer and related disease.
Showing 1-12 of 21
DLBclass – A Breakthrough in Diagnosing and Managing Diffuse Large B-cell Lymphoma
- Collaboration
- Licensing
Noninvasive Inflammation Imaging Using a CD45-PET Probe Aids in Diagnosis and Monitoring
- Collaboration
- Licensing
Treating Hematological Malignancies Such as Multiple Myeloma Targeting Extracellular Cyclophilin A (eCyPA) and CD147
- Collaboration
- Licensing